The figures below are Starpharma’s cash and cash equivalents (CCE) balance as stated in Quarterly Reports prior to a Capital Raising:
$17m bank balance, then
Capital Raising
$24m bank balance, then
Capital Raising
$26.1m bank balance, then
Capital Raising
$24.9m bank balance, then
Capital Raising
$15m today’s approximate bank balance
Based on Starpharma’s history, without a significant DEP deal with a large upfront licence fee, we may be getting quite close to the next capital raising.
Given the share price is near record lows, the next capital raising could be highly dilutive. Just saying.
*figures above compiled with best endeavour
SPL Price at posting:
9.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)